Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Matthias Rath
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Harvard multivitamin study=== Rath claimed that a [[Harvard School of Public Health]] study published in the ''[[New England Journal of Medicine]]''<ref>{{cite journal |vauthors=Fawzi W, Msamanga G, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter D | title = A randomized trial of multivitamin supplements and HIV disease progression and mortality | journal = N Engl J Med | volume = 351 | issue = 1 | pages = 23β32 | year = 2004 | pmid = 15229304 | doi = 10.1056/NEJMoa040541| s2cid = 674022 | url = http://researchonline.lshtm.ac.uk/9896/1/nejmoa040541.pdf }}</ref> validated claims that multivitamin supplementation slows the progression of HIV to AIDS. The study's authors released a statement condemning Rath's "irresponsible and misleading statements, as in our view they deliberately misinterpret findings from our studies to advocate against the scale-up of antiretroviral therapy."<ref name="harvard">[http://www.hsph.harvard.edu/press/releases/press05062005.html Statement from the authors of the Harvard School of Public Health study], stating that Rath has misused their study results. Retrieved 20 September 2006.</ref> The authors felt that Rath had misused their results to argue that multivitamins should be used ''in place of'' antiretroviral medication. They affirmed the central role of [[HAART|antiretroviral medication]] in treating AIDS and indicated that multivitamins should be at most a ''supplementary'' treatment.<ref name="harvard"/>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)